Migraine vs. Komodo Dragon: A Battle of Headache Proportions

MedEvidence Articles

This week we discuss episodic and chronic migraines. Migraines are primary headaches that affect about a billion people globally each year. In this weeks episode, we discuss symptoms and the differences between episodic and chronic migraines. Learn about risk factors, treatment options, and why accurate and appropriate treatment is critical to keep episodic migraines from getting worse.
Share with a friend. Rate, Review, and Subscribe to MedEvidence Articles to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn
Tiktok
Youtube

For more great content, including discussions by physicians and clinical research experts, check out the MedEvidence! podcast. www.MedEvidence.com

Thank you for listening!

References:

Safiri, S., et al. (2022). Global, regional, and national burden of migraine in 204 countries and territories, 1990 to 2019. Pain, 163(2), e293-e309. https://oce.ovid.com/article/00006396-202202000-00028/HTML

International Headache Society. (2018). 1. Migraine. IHS Classification ICHD-3. https://ichd-3.org/1-migraine/

Koren, M.J. & Toenjes, S. (Hosts). (2024). Two docs talk: Migraines. [Podcast Episode]. In MedEvidence! Truth Behind the Data. MedEvidence. https://medevidence.com/two-docs-talk-migraines

May, A., & Schulte, L. H. (2016). Chronic migraine: risk factors, mechanisms and treatment. Nature Reviews Neurology, 12(8), 455-464. https://www.nature.com/articles/nrneurol.2016.93

Young, N. P., et al. (2019). Episodic and chronic migraine in primary care. Headache: The Journal of Head and Face Pain, 59(7), 1042-1051. https://doi.org/10.1111/head.13543

Schürks, M., et al. (2009). Migraine and cardiovascular disease: systematic review and meta-analysis. Bmj, 339. https://www.bmj.com/content/339/bmj.b3914

Amiri, P., et al. (2022). Migraine: a review on its history, global epidemiology, risk factors, and comorbidities. Frontiers in neurology, 12, 800605. https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2021.800605/full

Bigal, M. E., et al. (2008). Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population‐based study. Headache: The Journal of Head and Face Pain, 48(8), 1157-1168. https://doi.org/10.1111/j.1526-4610.2008.01217.x

Mathew, N. T., Kurman, R., & Perez, F. (1990). Drug induced refractory headache‐clinical features and management. Headache: The Journal of Head and Face Pain, 30(10), 634-638. https://doi.org/10.1111/j.1526-4610.1990.hed3010634.x

Lipton, R. B., & Silberstein, S. D. (2015). Episodic and chronic migraine headache: breaking down barriers to optimal treatment and prevention. Headache: The Journal of Head and Face Pain, 55, 103-122. https://doi.org/10.1111/head.12505_2